| Title |
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
|
|---|---|
| Published in |
Psychopharmacology, May 2019
|
| DOI | 10.1007/s00213-019-05246-8 |
| Pubmed ID | |
| Authors |
Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin, Johannes G. Ramaekers, Ryan Vandrey, Christopher Irwin, Paul S. Haber, Iain S. McGregor |
X Demographics
The data shown below were collected from the profiles of 85 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 11 | 13% |
| United States | 9 | 11% |
| Canada | 8 | 9% |
| Spain | 7 | 8% |
| United Kingdom | 6 | 7% |
| Colombia | 2 | 2% |
| Argentina | 1 | 1% |
| Norway | 1 | 1% |
| Central African Republic | 1 | 1% |
| Other | 9 | 11% |
| Unknown | 30 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 53 | 62% |
| Scientists | 20 | 24% |
| Practitioners (doctors, other healthcare professionals) | 12 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 225 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 33 | 15% |
| Student > Ph. D. Student | 24 | 11% |
| Student > Bachelor | 24 | 11% |
| Student > Master | 22 | 10% |
| Other | 16 | 7% |
| Other | 32 | 14% |
| Unknown | 74 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 13% |
| Neuroscience | 22 | 10% |
| Psychology | 20 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 9% |
| Nursing and Health Professions | 9 | 4% |
| Other | 42 | 19% |
| Unknown | 83 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2022.
All research outputs
#499,150
of 25,698,912 outputs
Outputs from Psychopharmacology
#140
of 5,352 outputs
Outputs of similar age
#10,910
of 364,404 outputs
Outputs of similar age from Psychopharmacology
#5
of 64 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,352 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.